Abstract
Background
Attempts at identifying prognostic factors after hepatectomy in patients with colorectal liver metastases have not achieved consensus. We investigated prognostic factors ascertainable before hepatectomy for colorectal metastasis.
Method
Clinicopathological data for 149 consecutive patients with colorectal cancer who underwent curative resection of primary lesions and metastatic liver disease at one institution were subjected to multivariate analysis concerning metastatic status and the primary lesion.
Results
Poorly differentiated adenocarcinoma or mucinous carcinoma as the primary tumor (Poor/muc; P=0.026), marked vascular invasion by the primary tumor (V; P=0.002), bi-lobar liver metastases (P=0.048), and short doubling time (DT) of the liver tumor (P=0.028) were characteristics assessable before hepatectomy that independently indicated poorer survival. A four-stage classification based on these factors was related to overall (P<0.01) and disease-free (P<0.01) survival rates. No pattern of recurrence site was evident in stage I (patients with no risk factor). Recurrence was usually extrahepatic in stage IV (patients with Poor/muc) but favored the remnant liver in stage II (patients with bi-lobar metastases or short DT) or III (patients with V; P=0.037). Stage III showed more multiple and early hepatic recurrences than stage II, and repeat hepatectomy was less frequent (P<0.05).
Conclusion
Pre-hepatectomy prognostic staging should help to guide treatment of liver metastases.
Similar content being viewed by others
References
D’Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y (1997) Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 185:554–559
Fong Y, Fortner JG, Sun R, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–321
Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59–71
Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–522
Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785
Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Levi F (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663–669
Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth H (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal (liver) metastases. Ann Surg Oncol 8:347–353
Malafosse R, Penna C, Sa Cunha A, Nordlinger B (2001) Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 12:887–894
Yasui K, Hirai T, Kato T, Torii A, Uesaka K, Morimoto T, Kodera Y, Yamamura Y, Kito T, Hamajima N (1997) A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg 226:582–586
Collins VP, Loeffier RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol 76:988–1000
Staab HJ, Anderer FA, Hornung A, Stumpf E, Fischer R (1982) Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer 46:773–781
Havelaar IJ, Sugerbaker PH, Vermes M, Miller DL (1984) Rate of growth of intraabdominal metastases from colorectal cancer. Cancer 54:163–171
Fujii S (1994) Hepatic metastases development from colorectal cancer in view of CEA doubling time (in Japanese with English abstract). Yokohama Igaku 45:627–635
Shimada H, Nanko M, Fujii S, Masui H, Togo S, Ike H, Nakano A, Ohki S (1995) Treatment strategies for hepatic metastasis from colorectal cancer. J Hepatobiliary Pancreat Surg 2:116–121
Japanese Society for Cancer of the Colon and Rectum (1997) Japanese classification of colorectal carcinoma, 1st English edn. Kanehara, Tokyo
Kawasaki S, Makuuchi M, Kakazu T (1994) Resection for multiple metastatic liver tumors after portal embolization. Surgery 115:674–677
Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F, Bonalumi MG (1995) Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 82:377–381
Gayowski TJ, Iwatsuki S, Madariage JR, Selby R, Todo S, Irish W, Starzl TE (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703–711
Jatzko GR, Lisborg PH, Stettner HM, Klimpfinger MH (1995) Hepatic resection for metastases from colorectal carcinoma—a survival analysis. Eur J Cancer 31A:41–46
Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262
Scott S, Carty N, Anderson L, Taylor I (1995) Liver resection for colorectal liver metastases. Eur J Surg Oncol 21:33–35
Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE (1986) Liver resection for metastatic colorectal cancer. Surgery 100:804–809
Fortner JG (1988) Recurrence of colorectal cancer after hepatic resection. Am J Surg 155:378–382
Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, Bengmark S (1987) Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 11:541–547
Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78:797–801
Bozzetti F, Bignami P, Montalto F, Doci R, Gennari L (1992) Repeat hepatic resection for recurrent metastases from colorectal cancer. Br J Surg 79:146–148
Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T (2000) Indication for treatment strategies of colorectal liver metastases. Ann Surg 231:59–66
Minagawa Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg 231:487–499
Deans GT, Patterson CC, Parks TG, Spence RA, Heatley M, Moorehead RJ, Rowlands BJ (1994) Colorectal carcinoma: importance of clinical and pathological factors in survival. Ann R Coll Surg Engl 76:59–64
Goslin R, Steele G, Zamcheck N, Mayer R, Macintyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25:749–754
Savage AP, Malt RA (1992) Survival after hepatic resection for malignant tumours. Br J Surg 79:1095–1101
Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, Mochizuki H, Yamamoto J (2003) Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46 [10 Suppl]:S22–31
Yamada H, Kondo S, Okushiba S, Morikawa T, Katoh H (2001) Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg 25:1129–1133
Koga H, Moriya Y, Akasu T, Fujita S (1999) The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas. Eur J Surg Oncol 25:292–296
Bismuth H, Castaing D, Traynor O (1988) Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol 149:144–149
Griiffith KD, Sugarbaker PH, Chang AE (1990) Repeat hepatic resection for colorectal metastases. Surgery 81:101–104
Panis Y, Ribeiro J, Chretien Y, Nordlinger B (1994) Dormant liver metastases: an experimental study. Br J Surg 19:221–233
Slooter GD, Marquet RJ, Jeekel J, Ijzermans JNM (1995) Tumor growth stimulation after partial hepatectomy can be reduced by treatment with tumor necrosis factor alpha. Br J Surg 82:129–132
Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y (1998) Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124:57–64
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, K., Shimada, H., Fujii, Y. et al. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg 389, 371–379 (2004). https://doi.org/10.1007/s00423-004-0490-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-004-0490-y